Company / Current Assets per Share
Inhibikase Therapeutics, Inc. Current Assets per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$15.91
FY2024
5-year range
$0.97 / $15.91
FY2022-FY2024
Trend
+373.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +373% YoY in FY2024, a notable deviation from the 2-year average annual change of +310%.
Based on SEC 10-K filings.
15.91 in FY2024.
Improved from $0.97 to $15.91 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current assets per share increased 373.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $15.91 | +373.1% |
| FY2023 | $3.36 | +247.2% |
| FY2022 | $0.97 | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026